EXPERT TAX & ACCOUNTING SERVICES FOR BIOTECH AND LIFE SCIENCE
INNOVATE & GROW MARKET SHARE
Financial Solutions
for Biotech and Life Schience
Health and life sciences are entering a new era—driven by rapid advances in research, breakthrough therapies, and accelerating innovation in data, automation, and digital health. As the pace of discovery increases, the “business of science” is evolving just as quickly. Organizations are navigating tighter funding cycles, heightened regulatory expectations, complex supply chains, and growing scrutiny from investors, partners, and regulators—all while working to bring life-changing solutions to market.
As a CPA firm specializing in the health and life sciences industry, we help companies translate scientific progress into sustainable growth. From early-stage biotech and medtech to scaling life sciences organizations, we provide financial clarity, compliance confidence, and operational insight—so you can stay focused on innovation while building a strong, resilient business.
Solutions to Your Biggest Painpoints
High Costs & Inconsistent Margins
The Problem
Managing raw material costs, labor expenses, and production overhead while maintaining profitability is challenging without proper financial tracking.
Our Solution
We provide cost accounting systems, financial forecasting, and profitability analysis, ensuring manufacturers can track expenses, control costs, and improve margins at every stage of production.
Tax Puzzle
The Problem
Many startups leave credits on the table or lack the technical documentation needed to support the claim. R&D costs are misclassified, losing credits and creating audit risk
Our Solution
We coordinate a compliant R&D study, map activities to qualified research, and build an audit-ready file tied directly to your general ledger.
Grant funding and restricted funds
The Problem
Government and foundation grants can carry restrictions, milestones, and reporting requirements that don’t fit basic bookkeeping
Our Solution
We set up fund/class tracking and revenue recognition rules so financials reflect restrictions accurately and withstand sponsor or auditor review.
Equity compensation
The Problem
Equity compensation (409A, options, RSUs) is mishandled. Equity grants can trigger tax compliance issues and financial statement errors if valuations and reporting are not aligned.
Our Solution
We coordinate with your 409A provider, track grants and exercises, and ensure proper tax reporting and accounting treatment.
Due diligence readiness
The Problem
Missing schedules, inconsistent KPIs, and unclear cost allocation can slow a raise or reduce valuation confidence.
Our Solution
We create a diligence-ready close package—supporting schedules, KPI definitions, and clean financials—so you’re prepared for investor scrutiny.
Build a Financial Platform for
Scalable Growth
-
Growise CPAs develop custom tax strategies, optimize deductions, and ensure full IRS and state tax compliance, helping you minimize liabilities and keep more of your revenue.
-
In biotech and life sciences, timing gaps between payroll, lab spend, and CRO invoices can make cash projections unreliable.
We build a 13-week cash forecast tied to your payables, trial budgets, and hiring plan so you can manage runway proactively.
-
Research companies are subject to frequent state audits and licensing reviews, making accurate financial records essential for compliance and investor confidence.
Growise CPAs provide detailed bookkeeping, regulatory compliance tracking, and audit-ready reporting, ensuring businesses can withstand audits and due diligence processes.
-
Growise CPAs provide financial modeling, budgeting, and capital planning, ensuring your business remains financially strong and positioned for expansion.
-
Without structured financial oversight, biotech companies risk mismanaged production costs, supply chain inefficiencies, and regulatory non-compliance.
We offer controller services that establish internal financial controls, compliance tracking, and cost analysis, ensuring your operations remain efficient and scalable.
